Travere Therapeutic TVTX
$47.00 −$1.30 (-2.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $47.29 +0.62%
Open$48.09
Prev close$48.30
Day range$46.90 – $49.35
Volume1.33M
Market cap$4.51B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$224.56M+36.2% YoY
Operating profit$45.01M+80.5% YoY
Net profit-$52.34M-303.6% YoY
Diluted EPS-$0.55-296.4% YoY
Free cash flow-$43.66M-3,847.6% YoY
Operating cash flow$98.20M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin98.8%
Operating margin-3.1%
Net margin-18.7%
Return on equity-252.7%
Return on assets-17.5%
Return on invested capital-23.9%
Current ratio3.00
Liabilities / assets97.3%
Cash & investments$471.82M
Total debt$609.84M
Net cash (debt)-$138.03M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $224.56M | $169.58M | $127.20M | $490.73M | $129.69M |
| Total Operating Revenue | $224.56M | $169.58M | $127.20M | $490.73M | $129.69M |
| Cost of Revenue | $10.84M | $9.24M | $26.77M | $10.34M | -$38.91M |
| Gross Profit | $213.73M | $160.35M | $100.43M | $480.39M | $168.60M |
| Operating Expense | $168.72M | $156.40M | $137.35M | $543.21M | $201.03M |
| Selling and Admin Expenses | $98.41M | $96.11M | $80.25M | $337.20M | $143.16M |
| Research & Development | $70.30M | $60.28M | $57.09M | $206.01M | $57.87M |
| Operating Profit | $45.01M | $3.95M | -$36.92M | -$62.82M | -$32.43M |
| Net Non-Operating Interest Income (Expense) | $1.56M | $1.22M | $284,000.00 | $1.97M | $296,000.00 |
| Non-Operating Interest Income | $3.70M | $3.36M | $2.58M | $12.72M | $2.59M |
| Non-Operating Interest Expense | $2.14M | $2.13M | $2.30M | $10.75M | $2.30M |
| Other Income (Expense) | -$113.51M | -$40.18M | -$91,000.00 | $11.58M | $11.07M |
| Special Income (Charges) | -$113.12M | – | – | $0.00 | $0.00 |
| -Less:Other Special Charges | $113.12M | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$391,000.00 | -$40.18M | -$91,000.00 | $11.58M | $11.07M |
| Pretax Profit | -$66.93M | -$35.00M | -$36.72M | -$49.27M | -$21.07M |
| Tax | -$5.90M | -$204,000.00 | -$120,000.00 | $988,000.00 | $921,000.00 |
| Net Profit | -$52.34M | -$34.80M | -$37.10M | -$25.55M | $2.73M |
| Profit from Continuing Operations | -$61.04M | -$34.80M | -$36.60M | -$50.26M | -$21.99M |
| Net Income from Discontinuous Operations | $8.70M | $0.00 | -$500,000.00 | $24.72M | $24.72M |
| Net Income to Parent Company | -$52.34M | -$34.80M | -$37.10M | -$25.55M | $2.73M |
| Net Income to Common Stockholders | -$52.34M | -$34.80M | -$37.10M | -$25.55M | $2.73M |
| Basic EPS | -$0.55 | -$0.37 | -$0.40 | -$0.29 | $0.03 |
| Diluted EPS | -$0.55 | -$0.37 | -$0.40 | -$0.29 | $0.03 |
| -General & Admin Expense | – | $96.11M | – | $337.20M | $101.69M |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $848.23M | $799.36M | $555.19M | $605.19M | $605.19M |
| Total Current Assets | $633.45M | $615.14M | $392.68M | $437.57M | $437.57M |
| Cash and Cash Equivalents & Short-Term Investments | $471.82M | $489.18M | $264.68M | $322.80M | $322.80M |
| -Cash and Cash Equivalents | $123.54M | $117.74M | $78.36M | $93.04M | $93.04M |
| -Short Term Investments | $348.28M | $371.44M | $186.31M | $229.76M | $229.76M |
| Receivables | $107.53M | $80.64M | $87.30M | $80.13M | $80.13M |
| -Accounts Receivable | $107.53M | $80.64M | $87.30M | $80.13M | $80.13M |
| Inventory | $10.52M | $7.84M | $6.36M | $5.88M | $5.88M |
| Other Current Assets | $43.58M | $37.49M | $34.35M | $28.76M | $28.76M |
| Total Non-Current Assets | $214.78M | $183.47M | $162.56M | $166.87M | $166.87M |
| Net PPE | $10.53M | $11.98M | $13.30M | $14.60M | $14.60M |
| -Gross PPE | $10.53M | $11.98M | $13.30M | $24.70M | $24.70M |
| Goodwill and Other Intangible Assets | $164.11M | $130.77M | $110.09M | $113.12M | $113.12M |
| -Other Intangible Assets | $164.11M | $130.77M | $109.29M | $113.12M | $113.12M |
| Other Non-Current Assets | $40.14M | $40.73M | $39.17M | $39.16M | $39.16M |
| Total Liabilities | $825.65M | $774.84M | $456.46M | $490.36M | $490.36M |
| Total Current Liabilities | $210.91M | $152.03M | $125.44M | $159.90M | $159.90M |
| Payables | $15.28M | $7.50M | $12.91M | $24.80M | $24.80M |
| -Accounts Payable | $15.28M | $7.50M | $12.91M | $24.80M | $24.80M |
| Current Accrued Expenses | $153.29M | $110.48M | $83.06M | $84.52M | $84.52M |
| Short-Term Debt and Capital Lease Obligation | $6.31M | $6.16M | $6.02M | $5.88M | $5.88M |
| -Current Capital Lease Obligation | $6.31M | $6.16M | $6.02M | $5.88M | $5.88M |
| Other Current Liabilities | $2.10M | $2.10M | $2.10M | $3.19M | $3.19M |
| Total Non-Current Liabilities | $614.73M | $622.81M | $331.02M | $330.46M | $330.46M |
| Long Term Debt and Capital Lease Obligation | $609.84M | $610.74M | $321.65M | $322.86M | $322.86M |
| -Long Term Debt | $603.51M | $602.78M | $312.08M | $311.72M | $311.72M |
| -Long Term Capital Lease Obligation | $6.33M | $7.96M | $9.57M | $11.13M | $11.13M |
| Other Non-Current Liabilities | $4.89M | $12.07M | $9.38M | $7.60M | $7.60M |
| Total Equity | $22.58M | $24.52M | $98.73M | $114.83M | $114.83M |
| Stockholders' Equity | $22.58M | $24.52M | $98.73M | $114.83M | $114.83M |
| Capital Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Common Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.62B | $1.57B | $1.61B | $1.59B | $1.59B |
| Retained Earnings | -$1.60B | -$1.54B | -$1.51B | -$1.47B | -$1.47B |
| Gains/Losses Not Affecting Retained Earnings | -$2.05M | -$1.12M | -$1.06M | -$1.19M | -$1.19M |
| -Goodwill | – | – | $800,000.00 | – | – |
| -Accumulated Depreciation | – | – | – | -$10.10M | -$10.10M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $98.20M | $58.07M | -$40.37M | $37.78M | $60.68M |
| Net cash flow from continuing operations | $74.70M | $58.07M | -$40.37M | $37.78M | $60.68M |
| Net Income from Continuing Operations | -$61.04M | -$34.80M | -$36.60M | -$50.26M | -$21.99M |
| Gain/Loss from Continuing Operations | $113.53M | – | – | – | – |
| Depreciation & Depletion & Amortization | $5.20M | $4.23M | $25.21M | $60.74M | $18.14M |
| Other Non-Cash Items | -$1.01M | $37.40M | -$4,000.00 | $183,000.00 | $1.68M |
| Change in Working Capital | -$5.42M | $28.50M | -$45.12M | -$14.00M | $52.67M |
| -Change in Receivables | -$41.92M | $6.64M | -$7.23M | -$26.97M | $28.67M |
| -Change in Inventory | -$2.60M | -$2.71M | -$742,000.00 | $5.02M | $1.18M |
| -Change in Prepaid Assets | -$3.01M | -$3.08M | -$6.38M | -$7.66M | $446,000.00 |
| -Change in Payables and Accrued Expense | $49.04M | $24.69M | -$32.71M | $28.76M | $23.59M |
| -Change in Other Current Liabilities | -$6.92M | $2.95M | $1.94M | -$9.70M | -$589,000.00 |
| Net cash flow from investing | -$119.63M | -$206.29M | $21.55M | $27.89M | -$104.84M |
| Net Cash Flow from Continuing Investing Activities | -$119.63M | -$206.29M | $21.55M | $27.89M | -$104.84M |
| Net Intangibles Purchase and Sale | -$141.87M | -$21.07M | -$22.18M | -$58.16M | -$19.24M |
| Net Investment Purchase and Sale | $22.24M | -$185.22M | $43.73M | $86.45M | -$85.51M |
| Financing Cash Flow | $27.29M | $187.52M | $4.20M | -$33.47M | $26.68M |
| Net Cash Flow from Continuing Financing Activities | $27.29M | $187.52M | $4.20M | -$33.47M | $26.68M |
| Net Issuance Payments Of Debt | $0.00 | – | – | -$68.90M | $0.00 |
| Proceeds from Stock Option Exercised | $27.89M | $30.20M | $4.73M | $37.54M | $27.20M |
| Net Other Financing Charges | -$603,000.00 | -$16.80M | -$525,000.00 | -$2.10M | -$525,000.00 |
| Ending Cash Balance | $123.54M | $117.74M | $78.36M | $93.04M | $93.04M |
| Net Change in Cash | $5.87M | $39.30M | -$14.61M | $32.21M | -$17.48M |
| Beginning Cash Balance | $117.74M | $78.36M | $93.04M | $58.54M | $110.93M |
| Effect of Exchange Rate Changes | -$59,000.00 | $72,000.00 | -$60,000.00 | $2.29M | -$413,000.00 |
| Free Cash Flow | -$43.66M | $37.00M | -$62.54M | -$20.37M | $41.81M |
| -Change In Other Working Capital | – | – | – | -$3.44M | -$622,000.00 |
| Cash Flow from Discontinued Operating Activities | – | – | – | $0.00 | $0.00 |
| Net Other Investing Changes | – | – | – | -$404,000.00 | -$470,000.00 |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
| Cash Flow from Discontinued Financing Activities | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on TVTX.
Sign in to join the discussion.